Publications by authors named "Thomas Brumby"

Claim this Profile
N
New strategies towards advanced CT contrast agents. Development of neutral and monoanionic sulfur-bridged W(V) dimeric complexes.
Hristo P Varbanov, Toma Glasnov, Ferdinand Belaj, Simon Herbert, Thomas Brumby

Dalton Trans· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient Routes to a Diverse Array of Amino Alcohol-Derived Chiral Fragments.
Sina Haftchenary, Shawn D Nelson, Laura Furst, Sivaraman Dandapani, Steven J Ferrara, Thomas Brumby

ACS Comb Sci· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2.
Erik Eggert, Roman C Hillig, Silke Koehr, Detlef Stöckigt, Jörg Weiske, Thomas Brumby

J Med Chem· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lab oddity prevails: discovery of pan-CDK inhibitor (R)-S-cyclopropyl-S-(4-{[4-{[(1R,2R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide (BAY 1000394) for the treatment of cancer.
Ulrich Lücking, Rolf Jautelat, Martin Krüger, Thomas Brumby, Philip Lienau

ChemMedChem· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors.
Rolf Jautelat, Thomas Brumby, Martina Schäfer, Hans Briem, Gerhard Eisenbrand

Chembiochem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis